Evidence map›Paper›PMID 32131438›Full record

ReviewCells2020

Small Molecule Wnt Pathway Modulators from Natural Sources: History, State of the Art and Perspectives.

Artem Blagodatski, Antonina Klimenko, Lee Jia, Vladimir L Katanaev

Abstract readReview
In one paragraph

Review in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Exploring the Impact of 3-Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. PGC-1: a key regulator in bone homeostasis.Journal of bone and mineral metabolism · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Hexane Extract ofLife (Basel, Switzerland) · 2021
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Artem BlagodatskiSchool of Biomedicine, Far Eastern Federal University, Vladivostok 690090, Russia.
Antonina KlimenkoSchool of Biomedicine, Far Eastern Federal University, Vladivostok 690090, Russia.
Lee JiaInstitute of Oceanography, Minjiang University, Fuzhou 350108, China.
Vladimir L KatanaevSchool of Biomedicine, Far Eastern Federal University, Vladivostok 690090, Russia.ORCID 0000-0002-7909-5617

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Wnt signaling is one of the major pathways known to regulate embryonic development, tissue renewal and regeneration in multicellular organisms. Dysregulations of the pathway are a common cause of several types of cancer and other diseases, such as osteoporosis and rheumatoid arthritis. This makes Wnt signaling an important therapeutic target. Small molecule activators and inhibitors of signaling pathways are important biomedical tools which allow one to harness signaling processes in the organism for therapeutic purposes in affordable and specific ways. Natural products are a well known source of biologically active small molecules with therapeutic potential. In this article, we provide an up-to-date overview of existing small molecule modulators of the Wnt pathway derived from natural products. In the first part of the review, we focus on Wnt pathway activators, which can be used for regenerative therapy in various tissues such as skin, bone, cartilage and the nervous system. The second part describes inhibitors of the pathway, which are desired agents for targeted therapies against different cancers. In each part, we pay specific attention to the mechanisms of action of the natural products, to the models on which they were investigated, and to the potential of different taxa to yield bioactive molecules capable of regulating the Wnt signaling.

Indexed as

Biological ProductsDrug DiscoveryHumansWnt Signaling PathwayBiological Productscancerdrug discovernatural productsregenerationWnt signaling

Identifiers

PMID32131438
PMCPMC7140537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.